Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Fermin Orgambide

Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested

On Wednesday, May 18, Clearmind Medicine Inc. (OTC:CMNDF) will meet with the Center for Drug Evaluation and Research (CDER), a department within the FDA.

The objective of the meeting is to discuss Clearmind’s proposed first-in-human study evaluating its proprietary drug candidate CMND-100, developed for the treatment of alcohol use disorder. Clearmind could later submit an investigational new drug application.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.